Authors:
Sharif, NA
Xu, SX
Crider, JY
McLaughlin, M
Davis, TL
Citation: Na. Sharif et al., Levobetaxolol (Betaxon(TM)) and other beta-adrenergic antagonists: Preclinical pharmacology, IOP-lowering activity and sites of action in human eyes, J OCUL PH T, 17(4), 2001, pp. 305-317
Citation: Jy. Crider et Na. Sharif, Functional pharmacological evidence for EP2 and EP4 prostanoid receptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells, J OCUL PH T, 17(1), 2001, pp. 35-46
Citation: Jy. Crider et al., Endogenous EP4 prostaglandin receptors coupled positively to adenylyl cyclase in Chinese hamster ovary cells: pharmacological characterization, PROS LEUK E, 62(1), 2000, pp. 21-26
Authors:
Sharif, NA
Crider, JY
Xu, SX
Williams, GW
Citation: Na. Sharif et al., Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: Focus on DP class prostanoids, J PHARM EXP, 293(2), 2000, pp. 321-328
Authors:
Griffin, BW
Klimko, P
Crider, JY
Sharif, NA
Citation: Bw. Griffin et al., AL-8810: A novel prostaglandin F-2 alpha analog with selective antagonist effects at the prostaglandin F-2 alpha (FP) receptor, J PHARM EXP, 290(3), 1999, pp. 1278-1284